Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.

[1]  C. Drakeley,et al.  Reduction of Malaria Transmission to Anopheles Mosquitoes with a Six-Dose Regimen of Co-Artemether , 2005, PLoS medicine.

[2]  R. Price,et al.  In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up , 2004, Antimicrobial Agents and Chemotherapy.

[3]  K. Barnes,et al.  Artemisinin‐based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa , 2004, Tropical medicine & international health : TM & IH.

[4]  B. Sharp,et al.  Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.

[5]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.

[6]  H. Ferguson,et al.  Plasmodium falciparum malaria disease manifestations in humans and transmission to Anopheles gambiae: a field study in Western Kenya , 2004, Parasitology.

[7]  M. Galinski,et al.  WHO, the Global Fund, and medical malpractice in malaria treatment , 2004, The Lancet.

[8]  P Garner,et al.  Artesunate combinations for treatment of malaria: meta-analysis , 2004, The Lancet.

[9]  C. Drakeley,et al.  Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short‐lived reduction in infectiousness for mosquitoes , 2004, Tropical medicine & international health : TM & IH.

[10]  B. Knols,et al.  Infectivity of Plasmodium falciparum gametocytes in patients attending rural health centres in western Kenya. , 2004, East African medical journal.

[11]  A. Sowunmi,et al.  Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs , 2003, Tropical medicine & international health : TM & IH.

[12]  M. Kolczak,et al.  Sulfadoxine-Pyrimethamine in Treatment of Malaria in Western Kenya: Increasing Resistance and Underdosing , 2003, Antimicrobial Agents and Chemotherapy.

[13]  P. Newton,et al.  A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. , 2003, Molecular biology and evolution.

[14]  R. Snow,et al.  Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. , 2003, The Lancet. Infectious diseases.

[15]  J. Beier,et al.  Treatment failure of pyrimethamine‐sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya , 2003, Tropical medicine & international health : TM & IH.

[16]  B. Sharp,et al.  Antifolate antimalarial resistance in southeast Africa: a population-based analysis , 2003, The Lancet.

[17]  J. Zucker,et al.  The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. , 2003, The American journal of tropical medicine and hygiene.

[18]  N. White,et al.  The de novo selection of drug–resistant malaria parasites , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[19]  S. Lindsay,et al.  The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  C. Drakeley,et al.  Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. , 2002, The American journal of tropical medicine and hygiene.

[21]  C. Plowe,et al.  Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. , 2002, The Journal of infectious diseases.

[22]  A. Muñoz,et al.  Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. , 2002, American journal of epidemiology.

[23]  C. Rogier,et al.  Combating malaria in Africa. , 2002, Trends in parasitology.

[24]  L. Aarons,et al.  Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection , 2002, Parasitology.

[25]  Mathieu Nacher,et al.  DECREASED HEMOGLOBIN CONCENTRATIONS, HYPERPARASITEMIA, AND SEVERE MALARIA ARE ASSOCIATED WITH INCREASED PLASMODIUM FALCIPARUM GAMETOCYTE CARRIAGE , 2002, The Journal of parasitology.

[26]  P. Brey,et al.  Plasmodium sex determination and transmission to mosquitoes. , 2002, Trends in parasitology.

[27]  R. Snow,et al.  The past, present and future of childhood malaria mortality in Africa. , 2001, Trends in parasitology.

[28]  A. Buckling,et al.  The effect of partial host immunity on the transmission of malaria parasites , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[29]  C. Drakeley,et al.  Risk factors for gametocyte carriage in Gambian children. , 2001, The American journal of tropical medicine and hygiene.

[30]  R. Price,et al.  Factors contributing to anemia after uncomplicated falciparum malaria. , 2001, The American journal of tropical medicine and hygiene.

[31]  C. Drakeley,et al.  Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.

[32]  J. Trape.  The public health impact of chloroquine resistance in Africa. , 2001, The American journal of tropical medicine and hygiene.

[33]  I. Bygbjerg,et al.  Observations on the periodicity of Plasmodium falciparum gametocytes in natural human infections. , 2000, Acta tropica.

[34]  R. Price,et al.  Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[35]  C. Drakeley,et al.  Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. , 2000, The American journal of tropical medicine and hygiene.

[36]  Richard N. Price,et al.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study , 2000, The Lancet.

[37]  J. Trape,et al.  Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. , 2000, The American journal of tropical medicine and hygiene.

[38]  M. Newell.  Vertical transmission of HIV-1 infection. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[39]  E. Fèvre,et al.  Malaria-treatment policies: when and how should they be changed? , 1999, Annals of tropical medicine and parasitology.

[40]  R. Price,et al.  Risk factors for gametocyte carriage in uncomplicated falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.

[41]  N. White,et al.  Antimalarial drug resistance and combination chemotherapy. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[42]  R. Carter,et al.  Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction. , 1999, Molecular and biochemical parasitology.

[43]  C. Drakeley,et al.  Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.s. mosquitoes , 1999, Tropical medicine & international health : TM & IH.

[44]  C. Mendis,et al.  The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. , 1998, The American journal of tropical medicine and hygiene.

[45]  R. Price,et al.  Effects of artemisinin derivatives on malaria transmissibility , 1996, The Lancet.

[46]  K. Mendis,et al.  Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. , 1993, Immunology.

[47]  F. T. Ter Kuile,et al.  Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. , 1993, Experimental parasitology.

[48]  W. Watkins,et al.  Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[49]  T. Harinasuta,et al.  EFFECT OF PRIMAQUINE ON GAMETOCYTES OF PLASMODIUM FALCIPARUM IN THAILAND , 1980, The Lancet.

[50]  D E EYLES,et al.  Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. , 1955, The American journal of tropical medicine and hygiene.